EX-10.1
from 10-Q
2 pages
Certain Confidential Information Contained in This Documents, Marked by [***], Has Been Omitted Because Bolt Biotherapeutics, Inc. Has Determined the Information (I) Is Not Material and (II) Would Likely Cause Competitive Harm to Bolt Biotherapeutics, Inc. if Publicly Disclosed. Certain Confidential Information Contained in This Documents, Marked by [***], Has Been Omitted Because Bolt Biotherapeutics, Inc. Has Determined the Information (I) Is Not Material and (II) Would Likely Cause Competitive Harm to Bolt Biotherapeutics, Inc. if Publicly Disclosed
12/34/56
EX-10.2
from S-1/A
18 pages
Bolt Biotherapeutics, Inc. (Fka Bolt Therapeutics, Inc.) Amended and Restated 2015 Equity Incentive Plan Original Plan Adopted by the Board of Directors: April 20, 2015 Original Plan Approved by the Stockholders: April 20, 2016 Amended and Restated Plan Adopted by the Board of Directors: September 17, 2016 Amended and Restated Plan Adopted by the Stockholders: September 21, 2016 Amended and Restated Plan Adopted by the Board of Directors: July 25, 2018 Amended and Restated Plan Adopted by the Stockholders: July 25, 2018 Amended and Restated Plan Adopted by the Board of Directors: June 26, 2019 Amended and Restated Plan Adopted by the Stockholders: June 28, 2019 Amended and Restated Plan Adopted by the Board of Directors: June 26, 2020 Amended and Restated Plan Adopted by the Stockholders: June 28, 2020 Amended by the Compensation Committee: September 3, 2020
12/34/56